Table 2.
Relationship between Interleukin-8 (IL-8) and risk of 28-day mortality
IL-8 on admission vs 28 days follow-up death (Model 1 and 2) | ||||||
---|---|---|---|---|---|---|
Continuous IL-8 analysis (per SD increment) | P-value | Tertile 1 | Tertile 2 | Tertile 3 | P for trend | |
N/N eventsb | 46/13 | 15/1 | 16/3 | 15/9 | ||
HR (95% CI) (age and gender adjusted) | 3.88 (1.86–8.06) | <0.001 | 1.0 (ref) | 2.79 (0.29–26.89) | 10.02 (1.24–80.77) | 0.009 |
HR (95% CI) (age, gender and CRP adjusted)a | 3.76 (2.02–7.03) | <0.001 | 1.0 (ref) | 3.11 (0.32–29.93) | 13.47 (1.70–106.91) | 0.003 |
SD standard deviation, HR hazard ratio, CI confidence interval, CRP C-reactive protein
aBackward elimination model
bdeath within 28 days from admission